
|Articles|May 23, 2007
Wyeth CFO and VC to Leave the Company
Author(s)BioPharm International Editors
Kenneth J. Martin, Wyeth's (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June.
Advertisement
Kenneth J. Martin, Wyeth’s (Madison, NJ,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
4




